LB-102
LB-102-011
Phase 2 small_molecule active
Quick answer
LB-102 for Bipolar I Disorder is a Phase 2 program (small_molecule) at LB PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LB PHARMACEUTICALS INC
- Indication
- Bipolar I Disorder
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active